4//SEC Filing
Leonard Braden Michael 4
Accession 0001373604-25-000058
CIK 0001501756other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 6:07 PM ET
Size
8.0 KB
Accession
0001373604-25-000058
Insider Transaction Report
Form 4
Leonard Braden Michael
10% Owner
Transactions
- Purchase
Common Stock
2025-04-02$4.04/sh+15,209$61,408→ 2,757,526 total(indirect: Holdings of BML Investment Partners, L.P) - Purchase
Common Stock
2025-03-31$4.38/sh+19,566$85,668→ 2,742,317 total(indirect: Holdings of BML Investment Partners, L.P.)
Holdings
- 141,800
Common Stock
Footnotes (3)
- [F1]Represents shares purchased in multiple transactions resulting in a weighted average purchase price of $4.3784 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares bought at each separate price within the range.
- [F2]Represents shares purchased in multiple transactions resulting in a weighted average purchase price of $4.0376 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares bought at each separate price within the range
- [F3]BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
Documents
Issuer
Adverum Biotechnologies, Inc.
CIK 0001501756
Entity typeother
Related Parties
1- filerCIK 0001373603
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 6:07 PM ET
- Size
- 8.0 KB